Scholarlink

<p>The Berlin Heart EXCOR has been utilized as a bridge to transplant (BTT) in adult patients with end-stage heart failure. The aim of this short communication is to present our experience with post-transplant complications and outcomes in patients supported by the Berlin Heart EXCOR system. From January 2022 to December 2024, six patients with end-stage biventricular heart failure underwent implantation of the Berlin Heart EXCOR as a BTT. Three patients died while on support, and three patients successfully underwent transplantation. The median time to heart transplantation was 210&#xa0;days (range: 74–600&#xa0;days). One patient is alive and doing well 54&#xa0;months after heart transplantation. However, the other two patients died on postoperative days 16 and 133 due to intestinal ischemia and infection (<i>Pseudomonas aeruginosa</i> pneumonia and sepsis), respectively. In conclusion, although the results of our study are not very encouraging, they reflect outcomes in a critically ill group of patients with limited treatment options.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Heart Transplant Outcomes in Patients After Biventricular BerlinHeart EXCOR Device Support

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月25日

查看全文
  • Michal Hulman,
  • Panagiotis Artemiou,
  • Stefan Durdik,
  • Andrej Domonkos,
  • Peter Lesny,
  • Eva Goncalvesova,
  • Ivo Gasparovic

摘要

The Berlin Heart EXCOR has been utilized as a bridge to transplant (BTT) in adult patients with end-stage heart failure. The aim of this short communication is to present our experience with post-transplant complications and outcomes in patients supported by the Berlin Heart EXCOR system. From January 2022 to December 2024, six patients with end-stage biventricular heart failure underwent implantation of the Berlin Heart EXCOR as a BTT. Three patients died while on support, and three patients successfully underwent transplantation. The median time to heart transplantation was 210 days (range: 74–600 days). One patient is alive and doing well 54 months after heart transplantation. However, the other two patients died on postoperative days 16 and 133 due to intestinal ischemia and infection (Pseudomonas aeruginosa pneumonia and sepsis), respectively. In conclusion, although the results of our study are not very encouraging, they reflect outcomes in a critically ill group of patients with limited treatment options.